Anticorps Monoclonal anti-NeutraKine® EPO

NeutraKine® EPO Monoclonal Antibody for Neutralization, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

Neutralization, ELISA

Conjugaison

Non conjugué

CloneNo.

1D2H2

N° de cat : 69019-1-Ig

Synonymes

EP, EPO, Epoetin, erythropoietin, MVCD2, NeutraKine® EPO

---

Galerie de données de validation

• 

  Neutralization experiment of NeutraKine® EPO using 69019-1-Ig

  Recombinant human EPO (Cat.NO. HZ-1168) stimulates TF-1 cells (human erythroleukemic cell line) in a dose-dependent nammer (blue curve, refer to bottom X-left Y). The activity of human EPO (6 ng/mL HZ-1168) was neutralized by mouse anti-human EPO monoclonal antibody 69019-1-Ig at serial dose (red curve, refer to top X-right Y). The ND50 is typically 2-5 μg/mL.

• 

  Neutralization experiment of NeutraKine® EPO using 69019-1-Ig

  Recombinant human EPO (Cat.NO. HZ-1168) stimulates TF-1 cells (human erythroleukemic cell line) in a dose-dependent nammer (blue curve, refer to bottom X-left Y). The activity of human EPO (1 ng/mL HZ-1168) was neutralized by mouse anti-human EPO monoclonal antibody 69019-1-Ig at serial dose (red curve, refer to top X-right Y). The ND50 is typically 2-5 μg/mL. The NeutraControl mouse anti-human EPO monoclonal antibody 69519-1-Ig could recognize human EPO, but could not neutralize human EPO in the range of 0.019-80 μg/mL(green curve, refer to top X-right Y).

• 

  ELISA experiment of Recombinant protein using 69019-1-Ig

  Indirect ELISA was carried out by coating recombinant Human EPO (Cat.NO. HZ-1168) at 70 ng/well followed by blocking and adding serial diluted EPO antibody 69019-1-Ig and 69519-1-Ig respectively. Signal was developed with TMB and stopped by H2SO4. Signal strength was measured by absorbance at 450 nm.

---

Neutralization

Informations sur le produit

69019-1-Ig cible NeutraKine® EPO dans les applications de Neutralization, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Mouse / IgG1
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: human Humankine EPO protein HZ-1168
• Nom complet: erythropoietin
• Symbole du gène: EPO
• Identification du gène (NCBI): 2056
• Conjugaison: Non conjugué
• Forme: Lyophilized Powder
• Méthode de purification: Purification par protéine G
• Tampon de stockage: PBS stérile.
• Endotoxin: <0.1 EU/μg
• Reconstitution: This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
• Stability and Storage: Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

Informations générales

Erythropoietin (Epo) is a member of the EPO/TPO family and encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. Its effect is realized by binding erythropoietin receptor (EpoR) expressed on erythroid progenitor cells. EpoR, is a glycoprotein expressed on megakaryocytes, erythroid progenitors and endothelial cells. Epo also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types.

This antibody can be used to neutralize the bioactivity of EPO.

Produits associés

NeutraControl EPO Monoclonal antibody

69519-1-Ig